×
For best experience we recommend to activate Javascript in your browser.
CEACAM6 antibody (AA 93-221)
This anti-CEACAM6 antibody is a Rabbit Polyclonal antibody detecting CEACAM6 in WB, IHC, IP and ICC. Suitable for Human.
Quick Overview for CEACAM6 antibody (AA 93-221) (ABIN7613472)
Target
See all CEACAM6 Antibodies
CEACAM6
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6))
Reactivity
All reactivities for CEACAM6 antibodies
Human
Host
All hosts for CEACAM6 antibodies
Rabbit
Clonality
All clonalities for CEACAM6 antibodies
Polyclonal
Conjugate
All conjugates for CEACAM6 antibodies
This CEACAM6 antibody is un-conjugated
Application
All applications for CEACAM6 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CEACAM6 Antibody
(hide)
Binding Specificity
All epitopes for CEACAM6 antibodies
AA 93-221
Purpose
Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 (CEACAM6) Polyclonal Antibody
Sequence
Pro93~Ala221
Characteristics
The Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 (CEACAM6) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CEACAM6
(hide)
Target
CEACAM6
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6))
Alternative Name
CEACAM6
Gene ID
4680
UniProt
P40199
Recently viewed
(hide)
Chat with us , powered by LiveChat